Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jason Lowery

Physician Assistant Biloxi, MS Physician Assistant

NPI 1467471045 CMS profile 10694633

1720A Medical Park Dr, Suite 220, Biloxi, MS 39530

Open in the dashboard

General payments

$6,452

82 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Lowery of Biloxi, MS is reported in the CMS Open Payments database as having received $6,452 across 82 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,006 24
2024 General $751 17
2023 General $574 13
2022 General $3,687 22
2021 General $434 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Lowery
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jason Lowery were reported at $1,006. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jason Lowery Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $434 $132 $37–$438 $132
2022 $3,687 $155 $48–$522 $149
2023 $574 $167 $52–$557 $160
2024 $751 $178 $55–$600 $164
2025 $1,006 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $2,890 15 payments
  2. Ethicon US, LLC $1,443 48 payments
  3. Alon Medical Technology $1,322 8 payments
  4. Medical Device Business Services, Inc. $416 4 payments
  5. Acera Surgical, Inc. $184 1 payment
  6. Flexion Therapeutics, Inc. $108 1 payment
  7. Bioventus LLC $28 2 payments
  8. Molnlycke Health Care US, LLC $28 1 payment
  9. Heron Therapeutics, Inc. $18 1 payment
  10. GlaxoSmithKline, LLC. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Education $2,674 4 payments
  2. Food and Beverage $2,509 73 payments
  3. Travel and Lodging $1,269 5 payments
Products named General payments · program years 2021–2025
  1. VISTASEAL $590 20 payments
  2. N/A $330 13 payments
  3. Echelon; Endopath $284 9 payments
  4. STRATAFIX $268 4 payments
  5. ETHICON $199 2 payments
  6. Restrata Wound Matrix $184 1 payment
  7. Mepilex Border Post-Op Ag $138 5 payments
  8. Zilretta $108 1 payment
  9. Endopath $100 2 payments
  10. ECHELON ENDOPATH $45 1 payment
  11. Other $119 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

122

Median for Physician Assistant: 241

Drug cost

$704

Median for Physician Assistant: $4,110

Branded share of claims

29.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 36 $320
Methylprednisolone Generic 32 $178
Meloxicam Generic 18 $83
Diclofenac Sodium Generic 11 $74
Tramadol Hcl Generic 25 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 92 billing codes

Paid by Medicare

$111,901

Of which drugs: $49,627

Medicare patients

419

Average age 75

Services billed

28,826

260 women, 159 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 30%
Diabetes 29%
Chronic kidney disease 27%
Depression 21%
Atrial fibrillation 19%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 73 6,600 $33,692
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 13 19 $10,011
Injection, methylprednisolone acetate, 1 mg J1010 Office 164 19,960 $1,954
Injection, methylprednisolone acetate, 80 mg J1040 Office 35 48 $300
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 29 220 $141
Injection, ketorolac tromethamine, per 15 mg J1885 Office 41 100 $52
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 22 285 $25

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

82 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record